| Descriptor English: | Tumor Lysis Syndrome | ||||
| Descriptor Spanish: |
Síndrome de Lisis Tumoral
| ||||
| Descriptor Portuguese: | Síndrome de Lise Tumoral | ||||
| Descriptor French: | Syndrome de lyse tumorale | ||||
| Entry term(s): |
Syndrome, Tumor Lysis Syndrome, Tumour Lysis Syndromes, Tumor Lysis Syndromes, Tumour Lysis Tumor Lysis Syndromes Tumour Lysis Syndrome Tumour Lysis Syndromes |
||||
| Tree number(s): |
C15.604.515.880 C20.683.515.950 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015275 | ||||
| Scope note: | A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia. |
||||
| Annotation: | lymphoproliferative disord caused by anticancer drugs; coord IM with /etiol (not /chem ind) + anticancer drug /adv eff (IM) + required neopl coords /drug ther (IM or NIM) if pertinent |
||||
| Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||
| Previous Indexing: |
Antineoplastic Agents, Combined/adverse effects/therapeutic use (1980-1988) Antineoplastic Agents/therapeutic use (1984-1988) Burkitt's Lymphoma/complications (1980-1988) |
||||
| Public MeSH Note: | 89 |
||||
| History Note: | 89 |
||||
| Related: |
Tumor Necrosis Factor-alpha
MeSH | ||||
| DeCS ID: | 23852 | ||||
| Unique ID: | D015275 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 1989/01/01 | ||||
| Date of Entry: | 1988/05/19 | ||||
| Revision Date: | 2004/07/20 |
|
|
Tumor Lysis Syndrome
- Preferred
| Concept UI |
M0023515 |
| Scope note | A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia. |
| Preferred term | Tumor Lysis Syndrome |
| Entry term(s) |
Syndrome, Tumor Lysis Syndrome, Tumour Lysis Syndromes, Tumor Lysis Syndromes, Tumour Lysis Tumor Lysis Syndromes Tumour Lysis Syndrome Tumour Lysis Syndromes |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
